[ad_1] STOCKHOLM, Nov. 7, 2023 /PRNewswire/ — The Lancet publication of full Phase 3 data set In August we were excited to see the full data set from our Phase…
Tag: Calliditas
Everest Medicines’ Partner Calliditas Therapeutics Announces Full Results From NefIgArd Phase 3 Trial published in The Lancet
[ad_1] SHANGHAI, Aug. 17, 2023 /PRNewswire/ — Everest Medicines’ (HKEX 1952.HK, “Everest”, or the “Company”) partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) announced the publication in The…